We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
964
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.33%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVCT
3251
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
$100K ﹤0.01%
26,586
RSI icon
3252
Rush Street Interactive
RSI
$3.24B
$99K ﹤0.01%
+21,099
New +$126K
PLXP
3253
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$98K ﹤0.01%
+40,154
New +$112K
CO
3254
DELISTED
Global Cord Blood Corporation
CO
$98K ﹤0.01%
33,350
+16,892
+103% +$52.4K
GP
3255
GreenPower Motor Co
GP
$10.5M
$97K ﹤0.01%
2,944
-6,825
-70% -$356K
DBRG icon
3256
DigitalBridge
DBRG
$2.94B
$95K ﹤0.01%
+4,925
New +$120K
JSPRW icon
3257
CALL
Japer Therapeutics Warrants
JSPRW
$183K
$95K ﹤0.01%
48,495
-15,818
-25% -$3.07K
IMTX icon
3258
Immatics
IMTX
$1.24B
$94K ﹤0.01%
+10,693
New +$84.6K
NUVB icon
3259
Nuvation Bio
NUVB
$2.24B
$94K ﹤0.01%
+29,111
New +$127K
SNCR
3260
DELISTED
Synchronoss Technologies
SNCR
$94K ﹤0.01%
9,128
-8,927
-49% -$113K
LYTS icon
3261
LSI Industries
LYTS
$853M
$90K ﹤0.01%
14,403
-9,997
-41% -$64.2K
ORMP icon
3262
Oramed Pharmaceuticals
ORMP
$165M
$90K ﹤0.01%
+19,509
New +$104K
ABOS icon
3263
Acumen Pharmaceuticals
ABOS
$154M
$89K ﹤0.01%
18,808
-14,017
-43% -$52.7K
NEON icon
3264
Neonode
NEON
$13M
$89K ﹤0.01%
+17,266
New +$96.9K
EMBKW
3265
CALL
DELISTED
Embark Technology, Inc. Warrants
EMBKW
$87K ﹤0.01%
169,055
+62,430
+59% +$36.7K
OCGN icon
3266
Ocugen
OCGN
$410M
$85K ﹤0.01%
37,483
-126,072
-77% -$302K
WPRT
3267
Westport Fuel Systems
WPRT
$36.5M
$85K ﹤0.01%
8,524
+4,785
+128% +$59.3K
TUP
3268
DELISTED
Tupperware Brands Corporation
TUP
$85K ﹤0.01%
+13,388
New +$149K
LILM
3269
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$84K ﹤0.01%
35,758
-33,738
-49% -$106K
ICD
3270
DELISTED
Independence Contract Drilling, Inc.
ICD
$84K ﹤0.01%
+27,041
New +$105K
NAGE
3271
Niagen Bioscience
NAGE
$256M
$83K ﹤0.01%
49,451
-28,620
-37% -$56K
WKHS icon
3272
Workhorse Group
WKHS
$29.5M
$78K ﹤0.01%
+10
New +$94.4K
DOUG icon
3273
Douglas Elliman
DOUG
$155M
$77K ﹤0.01%
16,942
-107,651
-86% -$596K
LGHL
3274
Lion Group Holding
LGHL
$840K
0
CIFR icon
3275
Cipher Digital
CIFR
$9.47B
$75K ﹤0.01%
55,186

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 964 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.